natgillin/translations-raw huggingface dataset:
1 pre-filled syringe with 0.5 mL solution for injection
1 napunjena štrcaljka s 0,5 ml otopine za injekciju
1 pre-filled syringe with 0.5 ml solution for injection contains 20 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,5 ml otopine za injekciju sadrži 20 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.5 ml solution for injection contains 5 000 international units (IU) epoetin zeta (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,5 ml otopine za injekciju sadrži 5 000 internacionalnih jedinica (IU) epoetina zeta (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.5 ml solution for injection contains 5 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,5 ml otopine za injekciju sadrži 5 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.6 ml solution for injection contains 2 000 international units (IU) epoetin zeta (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,6 ml otopine za injekciju sadrži 2 000 internacionalnih jedinica (IU) epoetina zeta (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.6 ml solution for injection contains 2 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,6 ml otopine za injekciju sadrži 2 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.6 ml solution for injection contains 6 000 international units (IU) epoetin zeta (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,6 ml otopine za injekciju sadrži 6 000 internacionalnih jedinica (IU) epoetina zeta (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.6 ml solution for injection contains 6 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,6 ml otopine za injekciju sadrži 6 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.75 ml solution for injection contains 30 000 international units (IU) epoetin zeta (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,5 ml otopine za injekciju sadrži 30 000 internacionalnih jedinica (IU) epoetina zeta (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.75 ml solution for injection contains 30 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,75 ml otopine za injekciju sadrži 30 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.8 mL
1 napunjena štrcaljka s 0,8 ml
1 pre-filled syringe with 0.8 ml solution for injection contains 8 000 international units (IU) epoetin zeta (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,8 ml otopine za injekciju sadrži 8 000 internacionalnih jedinica (IU) epoetina zeta (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.8 ml solution for injection contains 8 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,8 ml otopine za injekciju sadrži 8 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.9 ml solution for injection contains 3 000 international units (IU) epoetin zeta (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,9 ml otopine za injekciju sadrži 3 000 internacionalnih jedinica (IU) epoetina zeta (rekombinantni humani eritropoetin).
1 pre-filled syringe with 0.9 ml solution for injection contains 3 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 0,9 ml otopine za injekciju sadrži 3 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 1 ml solution for injection contains 10 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 1 ml otopine za injekciju sadrži 10 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 1 ml solution for injection contains 40 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 1 ml otopine za injekciju sadrži 40 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 1.0 ml solution for injection contains 10 000 international units (IU) epoetin zeta* (recombinant human erythropoietin).
1 napunjena štrcaljka s 1,0 ml otopine za injekciju sadrži 10 000 internacionalnih jedinica (IU) epoetina zeta* (rekombinantni humani eritropoetin).
1 pre-filled syringe with 1.2 ml solvent for reconstitution contains: sodium chloride solution 5.4 mg/ml.
1 napunjena štrcaljka s 1,2 ml otapala za pripremu otopine sadrži: otopinu natrijevog klorida od 5,4 mg/ml.
1 pre-filled syringe with 2 ml solvent 1 safety-engineered needle
1 napunjena štrcaljka s 2 ml otapala 1 igla sa zaštitnim mehanizmom
1 pre-filled syringe with 2.5 ml water for injections
1 napunjenu štrcaljku s 2,5 ml vode za injekcije
1 pre-filled syringe with 4 ml solvent 1 vial adapter
1 napunjena štrcaljka s 4 ml otapala 1 nastavak za bočicu
1 pre-filled syringe with 5 ml solvent
1 napunjena štrcaljka s 5 ml otapala
1 pre-filled syringe with automatic needle guard (blistered)
1 napunjena štrcaljka s
1 PRE-FILLED SYRINGE WITH NEEDLE
1 NAPUNJENA ŠTRCALJKA S IGLOM
1 pre-filled syringe with needle guard
1 napunjena štrcaljka sa automatskim štitnikom za iglu (u blisteru)
1 pre-filled syringe with needle guard
1 napunjena štrcaljka sa štitnikom za iglu
1 pre-filled syringe with needle guard
1 napunjenu štrcaljku sa štitnikom za iglu
1 pre-filled syringe with needleguard (0.8 ml sterile solution) in a blister, and 1 alcohol pad.
1 napunjena štrcaljka sa štitnikom za iglu (0,8 ml sterilne otopine) u blisteru, i 1 jastučić natopljen alkoholom.
1 pre-filled syringe with safety device
1 napunjena štrcaljka sa sigurnosnom napravom
1 pre-filled syringe with safety device containing 0.5 mL 5 pre-filled syringes containing 0.5 mL
1 napunjena štrcaljka sa zaštitom za iglu koja sadrži 0,5 ml 5 napunjenih štrcaljki koje sadrže po 0,5 ml
1 pre-filled syringe with safety device containing 0.8 mL 5 pre-filled syringes containing 0.8 mL
1 napunjena štrcaljka sa zaštitom za iglu koja sadrži 0,8 ml 5 napunjenih štrcaljki koje sadrže po 0,8 ml
1 pre-filled syringe with safety device containing 1 ml.
1 napunjena štrcaljka sa sigurnosnom napravom koje sadrže 1 ml.
1 pre-filled syringe with solvent
1 napunjenu štrcaljku s otapalom
1 pre-filled syringe with solvent for parenteral use.
1 napunjena štrcaljka s otapalom za parenteralnu uporabu.
1 pre-filled syringe with solvent for reconstitution
1 napunjenu štrcaljku s otapalom za pripremu otopine za primjenu
1 pre-filled syringe without needle 1 pre-filled syringe with 1 needle
1 napunjena štrcaljka bez igle
1 pre-filled syringe.
Jedna napunjena štrcaljka.
1 pre-filled syringe: EU/1/12/798/005 4 pre-filled syringe: EU/1/12/798/006
1 napunjena štrcaljka: EU/1/12/798/005 4 napunjene štrcaljke: EU/1/12/798/006
1 pre-filled syringe: solvent 1 dose (0.5 ml)
1 napunjena štrcaljka: otapalo 1 doza (0,5 ml)
1 pre-filled syringe: solvent 2 needles
1 napunjena štrcaljka: otapalo 2 igle
1 prefilled syringe
1 napunjena štrcaljka
1 prefilled syringe + 1 needle
1 napunjena štrcaljka + 1 igla
1 prefilled syringe contains 10 ml water for injections.
1 napunjena štrcaljka sadrži 10 ml vode za injekcije.
1 prefilled syringe of 4 ml solvent with backstop (polypropylene), a rubber plunger (bromobutyl) and a tipcap with a stopper (bromobutyl)
1 napunjenu štrcaljku sa 4 ml otapala s graničnikom (polipropilen), gumenim klipom (brombutil) i zatvaračem vrha s čepom (brombutil)
1 PREFILLED SYRINGE WITH 1 NEEDLE
1 NAPUNJENA ŠTRCALJKA S 1 IGLOM
1 prefilled syringe with one needle (27G1/2) or 4 pre-filled syringes with 4 needles (27G1/2).
1 napunjena štrcaljka s jednom iglom (27G1/2) ili 4 napunjene štrcaljke s 4 igle (27G1/2).
1 prefilled syringe with one needle (27G1/2) or 6 pre-filled syringes with 6 needles (27G1/2).
1 napunjena štrcaljka s jednom iglom (27G1/2) ili 6 napunjenih štrcaljki sa 6 igala (27G1/2).
1 prefilled syringe with one needle (30G1/2) or 6 pre-filled syringes with 6 needles (30G1/2).
1 napunjena štrcaljka s jednom iglom (30G1/2) ili 6 napunjenih štrcaljki sa 6 igala (30G1/2).
1 prefilled syringe with solvent
1 napunjenu štrcaljku s otapalom
1 prepared syringe containing Ceplene.
1 pripremljenu štrcaljku koja sadrži Ceplene.
1 Previously known as Aripiprazole Pharmathen.
1 Ranije poznat pod imenom Aripiprazole Pharmathen.
1 Previously known as BTVPUR AlSap 1-8
1 Prethodno poznat kao BTVPUR AlSap 1 – 8
1 Previously known as Irbesartan Hydrochlorothiazide Winthrop.
1 Prethodno poznat kao Irbesartan Hydrochlorothiazide Winthrop.
1 Previously known as Irbesartan Krka.
1 Prethodno poznat kao Irbesartan Winthrop.
1 Previously known as Irbesartan Winthrop.
1 Prethodno poznat kao Irbesartan Winthrop.
1 Previously known as Maruxa.
1 Prethodno poznat kao Maruxa.
1 Previously known as Olanzapine Neopharma.
1 Ranije poznato pod nazivom Olanzapine Neopharma.
1 Previously known as Optisulin
1 Prethodno poznat kao Optisulin
1 Previously known as Para-aminosalicylic acid Lucane
1 Prije poznato pod nazivom para-aminosalicilatna kiselina Lucane
1 Previously known as Pomalidomide Celgene.
1 Prethodno poznat kao Pomalidomide Celgene
1 Previously known as Tadalafil Lilly.
1 Prethodno poznat pod nazivom Tadalafil Lilly.
1 Previously known as Thalidomide Pharmion.
1 Prethodno poznat kao Thalidomide Pharmion.
1 Previously known as Zenas.
1 Prethodno poznat pod nazivom Zenas.
1 Previously known as Zylagren
1 Prethodno poznat kao Zylargen
1 Primary analysis was performed with a data cut-off date of 12 December 2012 and is considered the final analysis
1 Primarna analiza provedena je na temelju podataka prikupljenih do 12. prosinca 2012. i smatra se završnom analizom
1 Primary and Secondary Outcome of double-blind Trial
1 Primarni i sekundarni ishodi dvostruko slijepog ispitivanja
1 Primary efficacy endpoint (International Myeloma Working Group criteria) CI = confidence interval; NE = not estimable; MR = minimal response
1 Primarna mjera ishoda za djelotvornost (kriteriji Međunarodne radne skupine za mijelom)
1 Produced in chick embryo cells
1 Proizveden u stanicama pilećeg embrija
1 produced in E. coli cells by recombinant DNA technology
1 proizvedeno u stanicama E. coli tehnologijom rekombinantne DNK
1 Produced in human diploid (MRC-5) cells
1 Umnožen na ljudskim diploidnim (MRC-5) stanicama
1 Progression of disability was defined as at least a 1.0 point increase on the EDSS from a baseline EDSS >=1.0 sustained for 12 or 24 weeks or at least a 1.5 point increase on the EDSS from a baseline EDSS =0 sustained for 12 or 24 weeks.
1 Progresija onesposobljenosti određena je kao povećanje za najmanje 1,0 vrijednost EDSS od početne vrijednosti EDSS >=1,0 u trajanju barem 12 ili 24 tjedna ili kao povećanje za najmanje 1,5 vrijednosti EDSS od početne vrijednosti EDSS =0 u trajanju barem 12 ili 24 tjedna.
1 protective mat
1 zaštitna podloga
1 protective mat
1 zaštitnu podlogu
1 q21 d.
vakih 21 dan
1 q2l d.
vakih 21 dan
1 Rate based on immediate-release exenatide completed long-term efficacy and safety studies n=5763 total (patients on sulphonylurea n=2971).
1 Stopa temeljena na podacima iz dovršenih dugoročnih ispitivanja sigurnosti i djelotvornosti eksenatida s trenutnim oslobađanjem , n = 5763 ukupno (bolesnika liječenih sulfonilurejom n = 2971).
1 Rate based on prolonged-release exenatide completed long-term efficacy and safety studies n=2868 total (patients on sulphonylurea n=1002).
1 Stopa na temelju podataka iz dovršenih dugoročnih ispitivanja sigurnosti i djelotvornosti eksenatida s produljenim oslobađanjem n=2868 ukupno (bolesnici na sulfonilureji n=1002).
1 Reassortant influenza virus* (live attenuated) of the following strains**:
1 Reasortirani virus gripe* (živi oslabljeni) sljedećih sojeva**:
1 Reported in infants only Paediatric population
1 Prijavljeno samo kod dojenčadi Pedijatrijska populacija
1 Reports of hypersensitivity have been received from post-approval marketing experience in association with the use of Hirobriz Breezhaler.
1 Prema iskustvima nakon stavljanja gotovog lijeka u promet zabilježeni su slučajevi preosjetljivosti povezani s primjenom Hirobriz Breezhalera.
1 Reports of hypersensitivity have been received from post-approval marketing experience in association with the use of Onbrez Breezhaler.
1 Prema iskustvima nakon stavljanja gotovog lijeka u promet zabilježeni su slučajevi preosjetljivosti povezani s primjenom Onbrez Breezhalera.
1 Reports of hypersensitivity have been received from post-approval marketing experience in association with the use of Oslif Breezhaler.
1 Prema iskustvima nakon stavljanja gotovog lijeka u promet zabilježeni su slučajevi preosjetljivosti povezani s primjenom Oslif Breezhalera.
1 represents the highest frequency observed either in the healthy adult or healthy older study population.
1 predstavlja najveću učestalost zabilježenu u zdrave odrasle ili zdrave starije populacije u ispitivanju.
1 results from subjects receiving either 100 mg QD (n=10: patients with serum creatinine >1.5 and 2.0 mg/dL) or 300 mg QD (n=509) were pooled for analyses.
1 rezultati ispitanika koji su primali 100 mg jednom dnevno (n=10: bolesnici s kreatininom u serumu >1,5 i 2,0 mg/dl) ili 300 mg jednom dnevno (n=509) su zbrojeni za potrebe analize.
1 reusable mixing bottle with lid and cap (note — the mixing bottle may become stained)
1 bocu za miješanje za višekratnu uporabu s poklopcem i zatvaračem (napomena — boca za miješanje može potamniti)
1 reusable mixing bottle with lid and cap (supplied in the kit)
1 boca za miješanje za višekratnu uporabu s poklopcem i zatvaračem (nalazi se u kompletu)
1 reusable oral dosing syringe
1 dozirnu štrcaljku za usta za višekratnu uporabu
1 reusable oral dosing syringe (supplied in the kit)
1 dozirna štrcaljka za usta za višekratnu uporabu (nalazi se u kompletu)
1 rue de Nungesser 59121 Prouvy France
1 rue de Nungesser 59121 Prouvy Francuska
1 sachet containing 1 cutaneous patch and 1 tube of cleansing gel (50 g).
vrećica sadrži 1 flaster za kožu i 1 tubu gela za čišćenje (50 g).
1 sachet containing the medicine drinking water (not included in the pack).
1 vrećicu s lijekom pitku vodu (nije uključena u pakiranje).
1 sachet contains 250 mg stiripentol.
1 vrećica sadrži 250 mg stiripentola.
1 sachet contains 500 mg stiripentol.
1 vrećica sadrži 500 mg stiripentola.
1 safety needle
1 sigurnosna igla
1 See section 4.4: pancreatitis and lipids
1 Vidjeti dio 4.4: pankreatitis i lipidi
1 See section 4.4: pancreatitis and lipids
1 Vidjeti dio 4.4: pankreatitis i lipidi c.
1 See section c.
1 Vidjeti dio c.
1 See section Description of selected adverse reactions
1 Vidjeti dio Opis izdvojenih nuspojava
1 See section ‘Description of selected adverse reactions’.
1 vidjeti dio 'Opis odabranih nuspojava'
1 See section “Description of selected adverse reactions” below
1 Vidjeti dolje navedeni dio „Opis odabranih nuspojava“
1 See section “Description of selected adverse reactions” below.
1 Vidjeti dio “Opis odabranih nuspojava“ ispod.
1 See subsections below for additional information
1 Za dodatne informacije vidjeti niže navedene odjeljke
1 SEM: Standard error of mean
1 SEM: Standardna pogreška srednje vrijednosti
1 separate needle
1 odvojena igla
1 seroprotection rate: proportion of subjects with haemagglutination inhibition (HI) titre 1:40
1stopa seroprotekcije: udio ispitanika s titrom inhibicije hemaglutinacije (HI) 1:40
1 seroprotection rate: proportion of subjects with haemagglutination inhibition (HI) titre 1:40 In study D-Pan-H1N1-008, the neutralising antibody responses were as follows:
1stopa seroprotekcije: udio ispitanika s titrom inhibicije hemaglutinacije (HI) 1:40 U ispitivanju D-Pan-H1N1-008, odgovor neutralizirajućih protutijela bio je sljedeći:
1 seroprotection rate: proportion of subjects with haemagglutination inhibition (HI) titre 1:40; 2booster seroconversion rate: proportion of subjects who were either seronegative at pre-booster and have a protective post-vaccination titre of 1:40, or who were seropositive at pre-booster and have a 4- fold increase in titre;
1stopa seroprotekcije: udio ispitanika koji su postigli titar inhibicije hemaglutinacije (HI) 1:40; 2stopa serokonverzije nakon docjepljivanja: udio ispitanika koji su bili seronegativni prije docjepljivanja i postigli zaštitni titar 1:40, ili koji su bili seropozitivni prije docjepljivanja i imali četverostruki porast titra;
1 sharp container
1 spremnik oštre predmete
1 sharp container
1 spremnik za oštre predmete
1 sharps container for disposal of pre-filled pen
1 spremnik za oštre predmete za zbrinjavanje brizgalica
1 sharps container for disposal of syringes
1 spremnik za oštre predmete za zbrinjavanje štrcaljki
1 Simeprevir in combination with sofosbuvir: pooled studies HPC2002, HPC3017 and HPC3018 (12 weeks) or study HPC2002 (24 weeks); simeprevir in combination with peginterferon alfa and ribavirin: pooled phase 3 studies C208, C216 and HPC3007 (first 12 weeks of treatments). see section below for further details.
1 Simeprevir u kombinaciji sa sofosbuvirom: objedinjena ispitivanja HPC2002, HPC3017 i HPC3018 (12 tjedana) ili ispitivanje HPC2002 (24 tjedna); simeprevir u kombinaciji s peginterferonom alfa i ribavirinom: objedinjena ispitivanja C208, C216 i HPC3007 faze 3 (prvih 12 tjedana liječenja). pogledati odjeljak niže za daljnje informacije.
1 single dose 0.5 ml pre-filled syringe without needle 10 single dose 0.5 ml pre-filled syringes without needle 20 single dose 0.5 ml pre-filled syringes without needle 50 single dose 0.5 ml pre-filled syringes without needle
1 jednodozna napunjena štrcaljka od 0,5 ml, bez igle 10 jednodoznih napunjenih štrcaljki od 0,5 ml, bez igle 20 jednodoznih napunjenih štrcaljki od 0,5 ml, bez igle 50 jednodoznih napunjenih štrcaljki od 0,5 ml, bez igle
1 single dose 1 ml pre-filled syringe without needle 10 single dose 1 ml pre-filled syringes without needle
1 jednodozna napunjena štrcaljka od 1 ml, bez igle 10 jednodoznih napunjenih štrcaljki od 1 ml, bez igle
1 single dose vial (powder) + 1 prefilled syringe (solvent) + 2 needles.
1 jednodozna bočica (prašak) + 1 napunjena štrcaljka (otapalo) + 2 igle.
1 single dose vial (powder) + 1 prefilled syringe (solvent) with needle.
1 jednodozna bočica (prašak) + 1 napunjena štrcaljka (otapalo) s iglom.
1 single dose vial (powder) + 1 prefilled syringe (solvent) without needle.
1 jednodozna bočica (prašak) + 1 napunjena štrcaljka (otapalo) bez igle.
1 single dose vial, 1 injection syringe of 1 mL, 1 injection needle and 1 cleansing swab
1 jednodozna bočica, 1 štrcaljka za injekciju od 1 ml, 1 igla za injekciju i 1 tupfer za čišćenje
1 single dose vial, 1 injection syringe of 2 mL, 1 injection needle and 1 cleansing swab
1 jednodozna bočica, 1 štrcaljka za injekciju od 2 ml, 1 igla za injekciju i 1 tupfer za čišćenje
1 single use 30 ml clear Type I glass vial with rubber stopper and aluminium cap with plastic seal of VFEND 200 mg, powder for solution.
1 staklenu bočicu od 30 ml (prozirno staklo tipa I) za jednokratnu uporabu s gumenim čepom i aluminijskim zatvaračem s platičnim zaštitnim zatvaračem koja sadrži VFEND 200 mg, prašak za otopinu.
1 single use pre-filled pen
1 napunjena brizgalica za jednokratnu uporabu
1 single use vial 4 single use vials
1 bočica za jednokratnu uporabu 4 bočice za jednokratnu uporabu
1 single use vial.
1 bočica za jednokratnu upotrebu.
1 single-dose (0.5 ml) pre-filled syringe with separate needle 1 single-dose (0.5 ml) pre-filled syringe without needle 10 single-dose (0.5 ml) pre-filled syringes with separate needles 10 single-dose (0.5 ml) pre-filled syringes without needle
1 jednodozna napunjena štrcaljka (0,5 ml) sa zasebno priloženom iglom 1 jednodozna napunjena štrcaljka (0,5 ml) bez igle 10 jednodoznih napunjenih štrcaljki (0,5 ml) sa zasebno priloženim iglama 10 jednodoznih napunjenih štrcaljki (0,5 ml) bez igle
1 single-dose (0.5 ml) vial.
1 jednodozna bočica (0,5 ml).
1 single-use nasal applicator (0.2 ml) 10 single-use nasal applicators (0.2 ml each)
1 aplikator za nos za jednokratnu uporabu 10 aplikatora za nos za jednokratnu uporabu (0,2 ml svaki)
1 single-use pre-filled pen and
1 napunjenu brizgalicu za jednokratnu primjenu i
1 small glass (maximum size 100 ml)
1 mala čaša (maksimalne veličine 100 ml)
1 soft capsule.
1 kapsula, meka
1 solvent vial
1 bočica s otapalom
1 solvent vial of 2.5 mL water for injections
1 bočicu otapala s 2,5 ml vode za injekcije
1 solvent vial of 5 mL water for injections
1 bočicu otapala s 5 ml vode za injekcije
1 spray
1 sprej
1 spray (100 microlitres) contains 100 micrograms fentanyl (as citrate)
Jedan potisak (100 mikrolitara) sadrži 100 mikrograma fentanila (u obliku fentanilcitrata).
1 starter pack containing 1 bottle, 1 reclosable bottle cap adapter and seven (7) CE marked oral syringes, 1 ml per carton
1 početno pakiranje sadrži 1 bocu, 1 nastavak za bocu s čepom za ponovno zatvaranje i sedam oralnih štrcaljki s oznakom CE od 1 ml po kutiji
1 starter pack containing 1 bottle, 1 reclosable bottle cap adapter and seven (7) CE marked oral syringes, 3 ml per carton
1 početno pakiranje sadrži 1 bocu, 1 nastavak za bocu s čepom za ponovno zatvaranje i sedam oralnih štrcaljki s oznakom CE od 3 ml po kutiji
1 starter pack containing 1 bottle, 1 reclosable bottle cap adapter and seven (7) CE marked oral syringes, 5 ml per carton and specific prescription.
1 početno pakiranje sadrži 1 bocu, 1 nastavak za bocu s čepom za ponovno zatvaranje i sedam oralnih štrcaljki s oznakom CE od 5 ml po kutiji.
1 sterile 1 ml Luer lock syringe.
1 sterilnu štrcaljku od 1 ml s priključkom tipa Luer lock
1 sterile 1 ml Luer lock syringe.
1 sterilnu štrcaljku od 1 ml s priključkom tipa Luer lock.
1 sterile graduated syringe with needle
1 sterilna graduirana štrcaljka s iglom
1 sterile infusion set 2 alcohol swabs
terilni set za infuziju vatice natopljene alkoholom 1 flaster
1 sterile injection syringe with needle.
1 sterilna štrcaljka za injekciju s iglom.
1 sterile matrix (7.5 x 10 cm)
1 sterilna matrica (7,5 x 10 cm)
1 sterile needle
1 sterilna igla
1 sterile needle
1 sterilnu iglu
1 sterile vial adapter 2 alcohol pads
terilni nastavak za bočicu jastučića natopljena alkoholom
1 sterile vial adapter for reconstitution with 1 butterfly needle and 2 alcohol swabs
1 sterilan nastavak za bočicu za rekonstituciju s 1 iglom s krilcima i 2 komprese natopljene alkoholom
1 sterile vial adapter.
1 sterilni nastavak za bočicu
1 sterile vial adapter.
1 sterilni nastavak za bočicu.
1 sterile vial adaptor for reconstitution
1 sterilni nastavak za bočicu za rekonstituciju
1 sterile, single use vial adapter.
1 sterilan nastavak za bočicu za jednokratnu uporabu.
1 Strains with MIC values above the Susceptible (S) breakpoint are rare, or not yet reported.
1 1 Sojevi s MIK vrijednostima iznad granične vrijednosti osjetljivosti (S) su rijetki ili do sada nisu zabilježeni.
1 Strains with MIC values above the Susceptible (S) breakpoint are rare, or not yet reported.
1 Sojevi s MIK vrijednostima iznad granične vrijednosti osjetljivosti (S) su rijetki ili do sada nisu zabilježeni.
1 Sun.
Sub 1 Sub 2
1 Suspension for
Suspenzija za injekciju
1 Suspension for injection
Suspenzija za injekciju
1 Swelling face
1 oticanje lica
1 Swelling face
mialgija
1 syringe
1 štrcaljka
1 syringe + 1 needle
1 štrcaljka + 1 igla
1 syringe contains: Urea, sodium chloride, polysorbate 20, sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, calcium chloride dihydrate, glycine, L-Leucine, L-Isoleucine, L- Threonine, L-glutamic acid, L-Phenylalanine, and water for injections.
1 štrcaljka sadrži: ureju, natrijev klorid, polisorbat 20, natrijev dihidrogenfosfat, natrijev hidrogenfosfat, kalcijev klorid, glicin, L-leucin, L-izoleucin, L-treonin, L- glutamatnu kiselinu, L- fenilalanin i vodu za injekcije